X-ALD Go-Live Announcement
The Colorado Newborn Blood spot Screening Program (CONBSP) will begin reporting results of X-ALD screening on Feb. 9, 2023. X-linked Adrenoleukodystrophy (X-ALD) occurs when the body is unable to break down fats — specifically, very long fatty acids. The excess fat can affect the nervous system and adrenal glands. The analyte for X-ALD is C26:0 Lysophosphatidylcholine (C26:0-LPC). CONBSP’s normal range for this analyte is 0.9 umol/L blood. Abnormal results require additional second tier LC/MS testing. Report language will reflect that the testing is not complete and additional testing is being performed. Once second tier testing is complete, the report will be updated to reflect a ‘normal’ or ‘abnormal’ result. Abnormal results will be called out to both the primary care provider (PCP) and specialists at Children’s Hospital (CHCO) in Aurora. ACT sheets to provide further guidance are available at the bottom of CONBSP’s webpage.
If you have any questions, contact Greg Bonn, manager of the Newborn Blood spot Screening Program , at 720-830-8992 or firstname.lastname@example.org.
Colorado Newborn Screening Program (CONBSP) Transition to E-Reports
Hello Newborn Screening colleagues:
As mentioned in previous monthly newsletters, the Colorado Newborn Screening Program (CONSP) will fully transition newborn screening reports to be obtained via E-report. Due to staffing and supply chain issues, this change will be effective on July 1, 2022. CONBSP will no longer send out physical mailers or fax the daily reports for the newborn screen to any health facilities. The only exception includes mailing abnormal reports and sending reports to health facilities that have an established courier pick-up from the State Lab. Reports can still be requested by phone or fax by submitting a completed results request form. Prior to calling or faxing, check E-portal. If the report is unavailable, contact the birthing facility.
By July 1, 2022, sign up for an E-report account to access the portal to obtain newborn screen reports. Send the completed agreement to email@example.com
Health care providers and laboratories
Abnormal Results | Education | Training | Quality Improvement (QI) | E-Report | Result Request
- Sickle cell screening and National Collegiate Athletic Association (NCAA) rules
- NBS Retention Schedule
- HB18-1006 Newborn Screening
- Newborn screening rules and regulations
- Newborn Screening Fees for Providers
- Newborn Screening cCMV Sample Release Policy
- Please Note:
- CONBSP will accept all necessary newborn blood spot screenings for an infant up to 12 months of life.
- For refugee status, knowing the infant’s age will help with the interpretation of the results since they will be evaluated outside of the usual parameters.
- Please Note:
Newborn Blood Spot Screening Phone: 303-692-3675 | Fax: 303-691-4008 | Email: firstname.lastname@example.org